Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cutera stock | 22.22

Own Cutera stock in just a few minutes.

Posted

Fact checked

Cutera, Inc is a medical devices business based in the US. Cutera shares (CUTR) are listed on the NASDAQ and all prices are listed in US Dollars. Cutera employs 447 staff and has a trailing 12-month revenue of around USD$156.5 million.

How to buy shares in Cutera

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Cutera. Find the stock by name or ticker symbol: CUTR. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cutera reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$22.22, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Cutera, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Cutera. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Cutera's share price?

Since the stock market crash in March caused by coronavirus, Cutera's share price has had significant negative movement.

Its last market close was USD$22.22, which is 17.95% down on its pre-crash value of USD$27.08 and 144.98% up on the lowest point reached during the March crash when the shares fell as low as USD$9.07.

If you had bought USD$1,000 worth of Cutera shares at the start of February 2020, those shares would have been worth USD$388.48 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$782.59.

Cutera share price

Use our graph to track the performance of CUTR stocks over time.

Cutera shares at a glance

Information last updated 2020-10-20.
Latest market close USD$22.22
52-week range USD$9.07 - USD$39.15
50-day moving average USD$18.5174
200-day moving average USD$14.7752
Wall St. target price USD$21.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-2.491

Buy Cutera shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cutera stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cutera price performance over time

Historical closes compared with the close of $22.22 from 2020-11-16

1 week (2020-11-20) -0.36%
1 month (2020-10-27) 10.00%
3 months (2020-08-27) 30.48%
6 months (2020-05-27) 66.94%
1 year (2019-11-27) -42.57%
2 years (2018-11-27) 7.08%
3 years (2017-11-27) -46.52%
5 years (2015-11-27) 54.20%

Is Cutera under- or over-valued?

Valuing Cutera stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cutera's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cutera's PEG ratio

Cutera's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 9.05. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cutera's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Cutera financials

Revenue TTM USD$156.5 million
Gross profit TTM USD$98.2 million
Return on assets TTM -14.68%
Return on equity TTM -59.62%
Profit margin -18.22%
Book value $2.988
Market capitalisation USD$338.9 million

TTM: trailing 12 months

Shorting Cutera shares

There are currently 608,572 Cutera shares held short by investors – that's known as Cutera's "short interest". This figure is 21.4% down from 773,951 last month.

There are a few different ways that this level of interest in shorting Cutera shares can be evaluated.

Cutera's "short interest ratio" (SIR)

Cutera's "short interest ratio" (SIR) is the quantity of Cutera shares currently shorted divided by the average quantity of Cutera shares traded daily (recently around 214285.91549296). Cutera's SIR currently stands at 2.84. In other words for every 100,000 Cutera shares traded daily on the market, roughly 2840 shares are currently held short.

However Cutera's short interest can also be evaluated against the total number of Cutera shares, or, against the total number of tradable Cutera shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cutera's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Cutera shares in existence, roughly 30 shares are currently held short) or 0.0473% of the tradable shares (for every 100,000 tradable Cutera shares, roughly 47 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cutera.

Find out more about how you can short Cutera stock.

Cutera share dividends

We're not expecting Cutera to pay a dividend over the next 12 months.

Cutera share price volatility

Over the last 12 months, Cutera's shares have ranged in value from as little as $9.07 up to $39.15. A popular way to gauge a stock's volatility is its "beta".

CUTR.US volatility(beta: 1.45)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cutera's is 1.449. This would suggest that Cutera's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cutera overview

Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, and myQ products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site